Position in IQV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,609,862
+$1,096,645 QoQ
Shares Held
34,209
+5.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#275
of 1,082 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $263,997,654 across 27 Diagnostics & Research names. IQV ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
90,308 | $45,276,818 | |
| 2 | WAT |
Waters Corp /De/
|
87,450 | $32,797,248 | |
| 3 | DHR |
Danaher Corp /De/
|
170,806 | $32,535,126 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
25,355 | $32,391,266 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
42,922 | $22,731,061 | |
| 6 | DGX |
Quest Diagnostics Inc
|
95,054 | $20,146,695 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
35,025 | $18,438,561 | |
| 8 | LH |
Labcorp Holdings Inc.
|
36,472 | $10,212,160 |
All Filings in IQV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,609,862 | 34,209 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,513,217 | 32,328 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,926,317 | 35,164 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,192,199 | 27,336 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $3,653,408 | 23,183 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $3,186,446 | 18,074 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,533,564 | 7,804 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,940,310 | 8,188 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,323,825 | 6,261 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,315,280 | 5,201 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,979,687 | 8,556 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,678,867 | 8,533 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,488,202 | 6,621 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,136,258 | 5,713 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,029,777 | 5,026 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $918,017 | 5,068 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $893,564 | 4,118 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $518,604 | 2,243 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $602,933 | 2,137 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $562,200 | 2,347 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $585,445 | 2,416 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $475,896 | 2,464 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $167,165 | 933 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $152,901 | 970 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $65,122 | 459 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||